Levi & Korsinsky notifies investors that it has commenced an investigation into Slide Insurance Holdings, Inc. (NASDAQ: SLDE) concerning potential violations of the federal securities laws.
On September 30, 2025, a Manatee Research report alleged Slide's underwriting margins are driven by claim denials and delays, rather than the "proprietary technology" previously touted by the company. The report also claims that Florida regulators ordered the removal of three senior executives due to prior roles at a failed insurer, though all three remain in place. Shares of Slide Insurance have fallen over 25% since the company's June IPO.
If you suffered a loss on your Slide securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) concerning potential violations of the federal securities laws.
On September 24, 2025, Acadia issued a press release "announcing top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients with hyperphagia in Prader-Willi syndrome (PWS)." The press release disclosed that the drug "did not demonstrate a statistically significant improvement over placebo on the study's primary endpoint, change from baseline to Week 12 on the Hyperphagia Questionnaire for Clinical Trials (HQ-CT), nor was there separation from placebo on any secondary endpoint." Acadia's Head of Research and Development stated that, "given these results, we do not intend to investigate intranasal carbetocin any further." On this news, Acadia's stock price fell $2.34 per share, or 9.92%, to close at $21.26 per share on September 24, 2025.
If you suffered a loss on your ACADIA securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Coherent Corp. (NYSE: COHR) concerning potential violations of the federal securities laws.
Coherent issued a press release on August 13, 2025, entitled "Coherent Announces Agreement to Sell Aerospace and Defense Business to Advent for $400 Million." The press release further stated that the "transaction is expected to close in the third quarter of calendar year 2025, subject to customary closing conditions." Following this news, Coherent's stock fell over 19% on August 14, 2025.
If you suffered a loss on your Coherent Corp. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Lesaka Technologies, Inc. (NASDAQ: LSAK) concerning potential violations of the federal securities laws.
Lesaka disclosed in a filing on September 10, 2025, with the U.S. Securities and Exchange Commission ("SEC") that the Audit Committee of its Board of Directors had "concluded that the Company's unaudited condensed consolidated financial statements for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025, respectively, included in the Company's Quarterly Reports on Form 10-Q for the quarters ended September 30, 2024, December 31, 2024, and March 31, 2025, respectively (the "Quarterly Reports"), should be restated, and that such unaudited condensed financial statements should no longer be relied upon, due to the Company's re-evaluation of the classification of certain revenue that has been reported as an agent rather than as principal, and related cost of goods sold." Following this news, Lesaka's stock price fell sharply during intraday trading on September 11, 2025.
If you suffered a loss on your Lesaka Technologies, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Matrix Service Company (NASDAQ: MTRX) concerning potential violations of the federal securities laws.
Matrix issued a press release on September 9, 2025, announcing its fiscal year 2025 fourth quarter and full-year results. For the quarter, Matrix reported non-GAAP earnings per share of -$0.28, missing consensus estimates by $0.29, and revenue of $216.4 million, missing consensus estimates by $15.85 million. Matrix stated that "[o]ur fourth quarter net income reflects a $14.9 million impact associated with four issues: a charge related to labor cost overruns on a crude oil terminal project, which is now complete; an updated reserve to a contract dispute on a project dating back to the pandemic, currently in arbitration; a charge for an unfavorable court decision related to a subcontractor's failure to pay lower tier contractors for another pandemic era project; and restructuring costs related to our organizational realignment." Following this news, Matrix's stock price fell over 13% on September 10, 2025.
If you suffered a loss on your Matrix Service Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Galiano Gold Inc. (NYSE: GAU) concerning potential violations of the federal securities laws.
Galiano issued a press release on September 9, 2025, describing "an incident that occurred at its Asanko Gold Mine" in Ghana, which "involved a confrontation between community members and military personnel on the Company's operating concessions[.]" Galiano stated that "[t]ensions escalated within the local community, leading to civil unrest, including a fatality and damage to contractor equipment." Following this news, Galiano's stock price fell over 7% on September 10, 2025.
If you suffered a loss on your Galiano Gold Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Skillz Inc. (NYSE: SKLZ) concerning potential violations of the federal securities laws.
Skillz disclosed in a filing with the U.S. Securities and Exchange Commission on September 2, 2025, that Tether Studios and its affiliate Tether Games (together, "Tether") plan to terminate all agreements with Skillz, effective September 1, 2025. Under the agreements, Skillz has licensed its software to Tether for use in monetizing Tether's games. In return, both companies share the revenue from user entry fees. After receiving the notice, Skillz filed a lawsuit on September 1, 2025, seeking to block Tether's termination of their agreements. Skillz is also disputing Tether's reasons for ending the deal. Following this news, Skillz's stock price fell over 17% on September 3, 2025.
If you suffered a loss on your Skillz Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Zai Lab Limited (NASDAQ: ZLAB) concerning potential violations of the federal securities laws.
Zai Lab issued a press release on September 3, 2025, announcing that "the final analysis of the Phase 3 FORTITUDE-101 trial evaluating bemarituzumab in combination with chemotherapy (mFOLFOX6) in first-line gastric cancer has been completed." While the interim analysis of the trial revealed a significant improvement in overall survival when compared to chemotherapy alone, the final analysis showed that the previously noted survival advantage had diminished. Zai Lab stated that "[b]ased on the updated results of the FORTITUDE-101 trial, Zai Lab intends to await the results of FORTITUDE-102, evaluating bemarituzumab in combination with nivolumab and chemotherapy in the same patient population, prior to regulatory filing. Data readout from FORTITUDE-102 is anticipated by the end of 2025 or the first half of 2026." Following this news, Zai Lab's American Depositary Receipt ("ADR") price fell over 6% on September 3, 2025.
If you suffered a loss on your Zai Lab Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Cybin Inc. (NYSE: CYBN) concerning potential violations of the federal securities laws.
Cybin issued a press release on September 2, 2025, "announcing that, effective September 2, 2025, Doug Drysdale will step down as the Company's Chief Executive Officer." Following this news, Cybin's stock price fell over 16% on September 2, 2025.
If you suffered a loss on your Cybin Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Axogen, Inc. (NASDAQ: AXGN) concerning potential violations of the federal securities laws.
Axogen issued a press release on August 25, 2025, "announcing that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) goal date for its Biologics License Application (BLA) for Avance® Nerve Graft by three months to December 5, 2025." Following this news, Axogen's stock price fell over 9% on August 25, 2025.
If you suffered a loss on your Axogen, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into EHang Holdings Limited (NASDAQ: EH) concerning potential violations of the federal securities laws.
EHang reduced its 2025 revenue projection to 500 million yuan from 900 million yuan, prompting Morgan Stanley to lower its forecasts for the Company on August 26, 2025. Following this news, EHang's American Depositary Receipt ("ADR") price fell over 7% on the same day.
If you suffered a loss on your EHang Holdings Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Tandem Diabetes Care, Inc. (NASDAQ: TNDM) concerning potential violations of the federal securities laws.
Tandem disclosed on August 7, 2025, that a malfunction had been identified in some of its insulin pumps, which could "trigger an error resulting in a discontinuation of insulin delivery," which "could result in hyperglycemia due to discontinuation of insulin delivery" and "may require hospitalization or intervention from a medical professional." Tandem stated that it had sent notices to impacted customers between July 22 and 24, 2025. Following this news, Tandem's stock price dropped.
If you suffered a loss on your Tandem Diabetes Care, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into AVITA Medical, Inc. (NASDAQ: RCEL) concerning potential violations of the federal securities laws.
AVITA reported second quarter 2025 results and revised its 2025 guidance, stating that the Company experienced a “significant headwind from a temporary gap in Medicare Administrative Contractor (MAC) payments to providers for the use of our flagship RECELL® System, which led to a weakening in demand. Multiple MACs initiated payments in July with resolution expected in Q3.” Following this report, the price of the Company’s stock dropped on August 7, 2025.
If you suffered a loss on your AVITA Medical, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Valneva SE (NASDAQ: VALN) concerning potential violations of the federal securities laws.
On August 25, 2025, before the market opened, Valneva announced that the FDA suspended the license for its chikungunya vaccine IXCHIQ due to new reports of serious adverse events consistent with chikungunya-like illness. The suspension is effective immediately and Valneva is required to stop the shipping and selling of its IXCHIQ vaccine in the U.S. Following this news, VALN’s stock price fell over 22% to open at $9.12 per share.
If you suffered a loss on your Valneva SE securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Coty Inc. (NYSE: COTY) concerning potential violations of the federal securities laws.
Coty issued a press release reporting its financial results its full fiscal year 2025 and fourth quarter on August 20, 2025. Among other items, Coty reported an unexpected loss and provided disappointing guidance. Discussing the results on an earnings call, Coty's Chief Financial Officer said that "[t]he challenges of fiscal year 2025 coincided with moderating profit in the broader beauty market," attributing sluggish sales to factors ranging from value-seeking behavior, innovation fatigue by consumers, and anti-theft and immigration policy changes. Following this news, Coty's stock price fell over 21% on August 21, 2025.
If you suffered a loss on your Coty Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Innovative Solutions and Support, Inc. (NASDAQ: ISSC) concerning potential violations of the federal securities laws.
IS&S issued a press release announcing its financial results for its fiscal third quarter of 2025 on August 14, 2025. Therein, the Company's Chief Executive Officer Shahram Askarpour advised, among other things, that a "pull-forward of F-16 production into the current quarter . . . will impact revenue over the next two quarters[.]" Following this news, IS&S's stock price fell over 31% on August 14, 2025.
If you suffered a loss on your Innovative Solutions and Support, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into CPI Card Group Inc. (NASDAQ: PMTS) concerning potential violations of the federal securities laws.
CPI announced second quarter 2025 financial results that missed top-line and bottom-line estimates on August 8, 2025. Among other items, CPI reported a GAAP earnings-per-share figure of $0.04 per share, missing estimates by $0.46, and revenue of $129.75M, missing estimates by $3.21M. In addition, the Company updated its outlook for 2025, stating that it expects net sales in low double-digit to mid-teens growth, compared to the prior outlook of mid-to-high single-digit growth. CPI stated that the change from the prior outlook reflects the addition of Arroweye Solutions, Inc.-an on-demand payment card solutions provider acquired by CPI in May 2025-partially offset by the negative impact of the accounting change for revenue recognition timing of work-in-process orders. Following this news, CPI's stock price fell over 28% on August 8, 2025.
If you suffered a loss on your CPI Card Group Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Bumble Inc. (NASDAQ: BMBL) concerning potential violations of the federal securities laws.
Bumble released its second quarter 2025 results, after the market closed on August 6, 2025. Among other items, the Company revealed that total paying users dropped 8.7% to 3.8 million in the second quarter, despite efforts to improve the quality of its user base and foster more meaningful connections by linking users with similar engagement and intent. For comparison, Bumble had 4 million paying users in the first quarter and 4.2 million in the fourth quarter of the previous year. In addition, the Company has rolled out new AI-powered features to expand trust and safety tools, but analysts have said the strategy will weigh on user and payer growth in the near term, especially as stricter verification measures roll out. Following this news, Bumble's stock price fell over 15% on August 7, 2025.
If you suffered a loss on your Bumble Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Sensus Healthcare, Inc. (NASDAQ: SRTS) concerning potential violations of the federal securities laws.
Sensus reported its financial results for the second quarter of 2025 on August 7, 2025, revealing a second quarter GAAP earnings-per-share figure of -$0.06, missing estimates by $0.09, and revenue of $7.3M, representing a -20.7% year-over-year decline and missing estimates by $2M. Sensus attributed the decrease in revenue primarily to a lower number of units sold to a large customer, partially offset by growth in recurring revenue from Fair Deal Agreements. Following this news, Sensus's stock price fell over 35% on August 8, 2025.
If you suffered a loss on your Sensus Healthcare, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Broadwind, Inc. (NASDAQ: BWEN) concerning potential violations of the federal securities laws.
Broadwind issued a press release announcing its financial results for the second quarter of 2025 on August 12, 2025. Among other results, the Company reported a GAAP loss per share of $0.04 for the quarter, missing consensus estimates by $0.05. The Company also suspended its previously issued full-year 2025 financial guidance as a result of a definitive agreement that it had entered into to sell its industrial fabrication operations in Manitowoc, Wisconsin. Following this news, Broadwind's stock price fell over 14% on August 12, 2025.
If you suffered a loss on your Broadwind, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Spirit Aviation Holdings, Inc. (NYSE: FLYY) concerning potential violations of the federal securities laws.
Spirit disclosed in a regulatory filing on August 11, 2025, that "there is substantial doubt as to the Company's ability to continue as a going concern within 12 months[.]" The Company cited, among other things, "adverse market conditions" and "minimum liquidity covenants in the Company's debt obligations and credit card processing agreement [that] require financial results to improve at a rate faster than what the Company is currently anticipating." Following this news, Spirit's stock price fell over 40% on August 12, 2025.
If you suffered a loss on your Spirit Aviation Holdings, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Collective Mining Ltd. (NYSE: CNL) concerning potential violations of the federal securities laws.
Morpheus Research published a report on August 6, 2025, entitled "Collective Mining: How To Build A Billion Dollar Company By Illegally Drilling on Untitled Land." Commenting on this report, Investing.com published an article which stated that Morpheus "alleges that Collective Mining is conducting exploration activities on untitled land without proper mining concessions from Colombian authorities, particularly at its flagship Apollo gold deposit." Following this news, Collective Mining stock dropped during intraday trading on the same day.
If you suffered a loss on your Collective Mining Ltd. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Praxis Precision Medicines, Inc. (NASDAQ: PRAX) concerning potential violations of the federal securities laws.
Praxis Precision Medicines, Inc. issued a press release on August 4, 2025, announcing its financial results for the second quarter of 2025. In addition to its financial disclosures, the Company reported mid-stage clinical trial results for its anti-seizure medication, vormatrigine. Praxis disclosed that 36 of 61 patients experienced treatment-emergent adverse events, and nearly 25% of study participants discontinued participation. Following this news, Praxis’s stock price fell over 5% on August 4, 2025.
If you suffered a loss on your Praxis Precision Medicines, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Insperity, Inc. (NYSE: NSP) concerning potential violations of the federal securities laws.
Insperity issued a press release on August 1, 2025, announcing its financial results for the second quarter of 2025. Among other disclosures, the company reported adjusted earnings per share of $0.26, which fell short of analyst expectations and represented a 70% decline compared to the same period in the prior year. Insperity attributed the disappointing results to higher-than-anticipated benefits costs, citing increased pharmacy expenses and a greater frequency of large insurance claims. The company also revised its full-year earnings guidance downward. Following this news, Insperity’s stock price fell over 24% on August 1, 2025.
If you suffered a loss on your Insperity, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Evolent Health, Inc. (NYSE: EVH) concerning potential violations of the federal securities laws.
On August 8, 2025, Evolent issued a press release announcing second quarter revenue results that were below analysts’ expectations. Management lowered its full-year revenue guidance attributing it to volatility in the managed care industry. Following this news, Evolent’s stock price fell by $1.30 per share to open at $8.39 per share.
If you suffered a loss on your Evolent Health, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Thomson Reuters Corporation (NASDAQ: TRI) concerning potential violations of the federal securities laws.
On August 6, 2025, Thomson Reuters published a press release reporting the Company’s second quarter 2025 results. During a same-day earnings call, top management acknowledged that the second quarter was buoyed by a favorable revenue mix and deferred expenses, both of which may fail to carry into the third quarter. Following this news, several analysts questioned the margin outlook and Thomson Reuter’s AI spending. Following this news, Thomson Reuter’s stock price fell over 9.9% to close at $179.97 per share on August 6, 2025.
If you suffered a loss on your Thomson Reuters Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Sabre Corporation (NASDAQ: SABR) concerning potential violations of the federal securities laws.
On August 7, 2025, Sabre announced disappointing second quarter results, missing revenue and earnings projections, and cutting its guidance for the remainder of 2025. Sabre’s revenue declined 1% compared to last quarter where the company projected single digit revenue growth. Management pointed to “the weakness of corporate bookings relative to leisure and the pullback of government and military travel … [which] caused GDS volumes to underperform passenger growth.” Following this news, Sabre’s stock price fell by $1.07 per share to close at $1.93 per share.
If you suffered a loss on your Sabre Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Confluent, Inc. (NASDAQ: CFLT) concerning potential violations of the federal securities laws.
Confluent issued a press release on July 30, 2025, announcing its financial results for the second quarter of 2025 and held a related earnings call. During the call, Confluent's Chief Financial Officer said that "consumption growth was impacted by continued optimization with month-over-month trends trailing the same period in prior years" and that "an AI-native customer has been making a broad-based move towards self-management of internal data platforms, reducing their Confluent Cloud usage as a result." Following this news, Confluent's stock price fell over 32% on July 31, 2025.
If you suffered a loss on your Confluent, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Gartner, Inc. (NYSE: IT) concerning potential violations of the federal securities laws.
On August 6, 2025, Gartner issued a press release announcing second quarter fiscal 2025 results, beating revenue and earnings expectations, but disappointing investors with a slowdown in its contract growth rate. The company further cut its annual revenue forecast, now expecting only $6.46 billion as compared to last quarter’s estimate of $6.54 billion. Management blamed the guide down on faltering CEO confidence levels due to tariff risks, resulting in the associated implementation of cost-cutting measures across potential corporate clients, as well as continued headwinds from DODGE initiatives making “it more challenging for clients to purchase or renew many of our products.” Following this news, Gartner’s stock price fell by $92.78 per share to close at $243.93 per share.
If you suffered a loss on your Gartner, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Six Flags Entertainment Corporation (NYSE: FUN) concerning potential violations of the federal securities laws.
On August 6, 2025, Six Flags issued a press release announcing disappointing second quarter fiscal 2025 results where the company’s profits swung to a loss of $100m. The company slashed its full year guide, now expecting earnings of $860 million to $910 million, down from prior guidance of $1.08 billion to $1.12 billion. In its release, Six Flags largely pointed to weather impact for the downturn, but further highlighted a reduction in both season pass sales and renewal rates. The company further announced its president and CEO, Richard Zimmerman, will step down by end of year. Following this news, Six Flags’ stock price fell by $4.98 per share to open at $25.72 per share.
If you suffered a loss on your Six Flags Entertainment Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Anika Therapeutics, Inc. (NASDAQ: ANIK) concerning potential violations of the federal securities laws.
Anika issued a press release on July 30, 2025, "announc[ing] topline results from its U.S. pivotal clinical trial of Hyalofast, a resorbable, hyaluronic acid scaffold used in conjunction with autologous bone marrow aspirate concentrate (BMAC) for cartilage repair." The press release stated that "[w]hile Hyalofast demonstrated consistent improvements in treated patients across all measures of pain and function relative to microfracture, the study did not meet its pre-specified co-primary endpoints. The study was likely impacted by both a higher subject dropout rate in the microfracture arm and missed visits during COVID. This resulted in missing data, which reduced the evaluable sample size and complicated the statistical analysis." Following this news, Anika's stock price fell over 27% on July 30, 2025.
If you suffered a loss on your Anika Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Align Technology, Inc. (NASDAQ: ALGN) concerning potential violations of the federal securities laws.
Align Technology, Inc. disclosed its financial results for the second quarter of 2025 on July 29, 2025, and revised its full-year outlook, a mere two months after management presented a multi-year Long-Range Plan at its Analyst Day. Despite prior guidance projecting mid-single-digit revenue growth, the company’s reported Q2 revenues were essentially flat year-over-year, establishing a lower-than-anticipated baseline for the balance of 2025. Following this news, Align Technology’s common stock declined over 31% in early trading on July 31, 2025.
If you suffered a loss on your Align Technology, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into GSK plc (NYSE: GSK) concerning potential violations of the federal securities laws.
GSK issued a press release on July 17, 2025, announcing "that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of Blenrep (belantamab mafodotin-blmf) combinations." Following this news, GSK's American Depositary Receipt ("ADR") price fell over 4% on July 17, 2025.
If you suffered a loss on your GSK plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Exelixis, Inc. (NASDAQ: EXEL) concerning potential violations of the federal securities laws.
Exelixis issued a press release on July 28, 2025, "report[ing] financial results for the second quarter of 2025" and "provid[ing] an update on progress toward achieving key corporate objectives, and outlined its commercial, clinical and pipeline development milestones." Among other items, Exelixis reported that net product revenues for cabozantinib were approximately 2% below the consensus estimate of $531.3 million. Exelixis also disclosed that "[b]ased on our evaluation of emerging data from the phase 2 portion of the STELLAR-305 study in advanced squamous cell carcinoma of the head and neck, emerging competition in this indication and assessment of other potentially larger commercial opportunities, we have made the decision not to proceed to the phase 3 portion of the trial." Following this news, Exelixis's stock price fell over 16% on July 29, 2025.
If you suffered a loss on your Exelixis, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Teva Pharmaceutical Industries Limited (NYSE: TEVA) concerning potential violations of the federal securities laws.
On July 31, 2025, Teva published a press release reporting the Company’s second quarter 2025 financial results. As part of the press release, Teva disclosed that generic product revenues were down. The Company’s management predicted a flat year for generic revenue globally, blaming the delay of certain generic launches. Following this news, Teva’s stock price fell over 8.2% to close at $15.45 per share on July 31, 2025.
If you suffered a loss on your Teva Pharmaceutical Industries Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Duolingo, Inc. (NASDAQ: DUOL) concerning potential violations of the federal securities laws.
On July 28, 2025, JMP Securities lowered its price target on Duolingo stock to $450 from $475, citing concerns about slowing user engagement ahead of the Company's second-quarter earnings report. Specifically, third party data suggested that daily active user growth decelerated to approximately 39% year-over-year in the second quarter, a noticeable drop from about 51% in the first quarter. Following this news, Duolingo's stock price fell over 6% on the same day.
If you suffered a loss on your Duolingo, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Fomento Econmico Mexicano, S.A.B. de C.V. (NYSE: FMX) concerning potential violations of the federal securities laws.
On July 28, 2025, Fomento issued a press release announcing their second quarter fiscal 2025 results well-below expectations with profit falling 60% year-over-year, resulting in earnings of only $0.40 per share. During the earnings call, management disclosed that despite growing revenue more than 6%, operating income increased only 0.2% since last year. Fomento put the blame on a “challenging consumer environment in Mexico” but also admitted that their “operations were geared to a stronger consumer environment [in Mexico] than the one that materialize, plus our cost and expenses ran a bit ahead of actual volume and traffic.” Following this news, Fomento’s stock price fell by $6.35 per share and is currently trading at $92.25 per share.
If you suffered a loss on your Fomento Econmico Mexicano, S.A.B. de C.V. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into ZEEKR Intelligent Technology Holding Limited (NYSE: ZK) concerning potential violations of the federal securities laws.
Reuters published an article on July 19, 2025, reporting that "Chinese electric vehicle brands Neta and Zeekr inflated sales in recent years to hit aggressive targets," citing "documents reviewed by Reuters and interviews with dealers and buyers." The article reported that "[t]he companies arranged for cars to be insured before they were sold to buyers, . . . enabling them under Chinese industry car registration practices to book sales early so they could hit the monthly and quarterly targets[.]" Following this news, Zeekr's American Depositary Receipt ("ADR") fell over 3% on July 21, 2025.
If you suffered a loss on your ZEEKR Intelligent Technology Holding Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Whirlpool Corporation (NYSE: WHR) concerning potential violations of the federal securities laws.
On July 29, 2025, Whirlpool issued a press release announcing positive second quarter results, featuring “sequential net sales growth across all segments” despite that “the second quarter continued to be impacted by competitors stockpiling Asian imports into the US.” Whirlpool further announced it would be considerably reducing its full-year guide due to the same continued impact from Asian importers and the general continued impact from the ongoing “uncertainty in the macro environment.” Full-year earnings were cut 30% at the midpoint with management now anticipating only $6 - $8 per share, down from $10. Management also informed investors during the call it would recommend the Board cut the company’s annual dividend by nearly 50%, down to $3.60 from $7. Following this news, Whirlpool’s stock price fell by $13.58 per share to open at $84.39 per share.
If you suffered a loss on your Whirlpool Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Barnes & Noble Education, Inc. (NYSE: BNED) concerning potential violations of the federal securities laws.
Barnes & Noble disclosed in a filing on July 18, 2025, with the U.S. Securities and Exchange Commission that its annual report for the fiscal year ended May 3, 2025 will be delayed due to an ongoing investigation regarding how the costs of digital sales were recorded. The investigation's early findings indicate that Barnes & Noble may have overstate accounts receivable by up to $23 million, and that the Company expects to report at least one material weakness tied to manual journal entries. Following this news, Barnes & Noble's stock price fell over 21% on July 21, 2025.
If you suffered a loss on your Barnes & Noble Education, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into MarineMax, Inc. (NYSE: HZO) concerning potential violations of the federal securities laws.
MarineMax issued a press release on July 24, 2025, reporting its financial results for the third quarter of 2025. Among other items, MarineMax cut its profit guidance by half at the midpoint to $0.45 to $0.95 per share, compared to prior guidance of $1.40 to $2.40 per share. MarineMax's Chief Executive Officer stated that "[a] combination of ongoing economic uncertainty, evolving trade policies and geopolitical tensions contributed to weak retail demand across the recreational marine industry in the June quarter," adding that the challenging business conditions is leading consumers to delay purchases until conditions improve. Following this news, MarineMax's stock price fell over 16% on July 24, 2025.
If you suffered a loss on your MarineMax, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Geely Automobile Holdings Limited (OTC: GELYY) concerning potential violations of the federal securities laws.
Reuters published an article on July 19, 2025, reporting that Geely's premium electric vehicle brand "Zeekr inflated sales in recent years to hit aggressive targets," citing "documents reviewed by Reuters and interviews with dealers and buyers." The article reported that Zeekr "arranged for cars to be insured before they were sold to buyers, . . . enabling them under Chinese industry car registration practices to book sales early so they could hit the monthly and quarterly targets[.]" Following this news, the value of Geely securities fell sharply.
If you suffered a loss on your Geely Automobile Holdings Limited securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Otis Worldwide Corporation (NYSE: OTIS) concerning potential violations of the federal securities laws.
On July 23, 2025, Otis reported its second quarter fiscal 2025 earnings, unveiling net sales for the quarter of $3.6 billion that fell below analysts’ expectations for $3.71 billion. Management noted that new-equipment sales declined 10%, worse than the market feared, in the quarter, triggering the company to reduce their annual guidance from $14.6 – $14.8 billion down to $14.5 – $14.6 billion in the second quarter. While the Company largely blamed the setback on challenges in China, in which new equipment sales fell 20% in the quarter, declines were also seen in the Americas and Asia Pacific. Following this news, Otis’ stock price fell by $12.79 per share to open at $88.20 per share.
If you suffered a loss on your Otis Worldwide Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Encompass Health Corporation (NYSE: EHC) concerning potential violations of the federal securities laws.
On July 15, 2025, the New York Times published an article, entitled “Even Grave Errors at Rehab Hospitals Go Unpenalized and Undisclosed,” discussing the state of the private rehabilitation hospital industry. In the article, the Times specifically identified Encompass as one of the for-profit rehab corporations that “have had rare but serious incident of patient harm and perform below average on two key safety measure tracked by Medicare.” The article went on to note specific examples highlighting significant patient safety concerns, medication errors, and an overall lack of oversight at Encompass’ hospitals. Following this news, Encompass’ stock price fell by $12.39 per share to close at $ 107.28 per share.
If you suffered a loss on your Encompass Health Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Simulations Plus, Inc. (NASDAQ: SLP) concerning potential violations of the federal securities laws.
Simulations Plus reported its financial results for its third fiscal quarter on July 14, 2025. Among other items, Simulations Plus reported sales of $20.4 million, missing the consensus estimate of $20.9 million. Simulations Plus also reported a net loss of $67.3 million and diluted loss per share of $3.35, reflecting a non-cash impairment charge of $77.2 million, compared to net income of $3.1 million and diluted earnings per share of $0.15 for the same period in 2024. The Company also revised its fiscal 2025 adjusted earnings guidance to $0.93 to $1.06, down from the previous guidance of $1.07 to $1.20. Simulations Plus advised investors that, in June, the Company had initiated a restructuring of its operations, including workforce reductions and cost-cutting measures, aimed at improving operational efficiency and reducing expenses. Following this news, Simulations Plus's stock price fell over 25% on July 15, 2025.
If you suffered a loss on your Simulations Plus, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Bruker Corporation (NASDAQ: BRKR) concerning potential violations of the federal securities laws.
On July 21, 2025, Bruker announced disappointing preliminary results for the second quarter, ended June 30, 2025. The Company disclosed earnings and revenue that both fell well-below expectations and announced an estimated 7% year-over-year organic revenue decline, significantly worse than management previously forecast. Bruker blamed soft demand from academic institutions and a slowdown in biopharma for the weakness in bookings, despite having last quarter “established a floor based on current headwinds” including concerns around academic uncertainty and the threat of biopharma tariffs. Following this news, Bruker’s stock price fell by $3.74 per share to open at $36.82 per share.
If you suffered a loss on your Bruker Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc (NASDAQ: MREO) concerning potential violations of the federal securities laws.
Mereo and its development partner Ultragenyx Pharmaceutical Inc. issued a press release on July 9, 2025, "announcing that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis[.]" Following a Data Monitoring Committee meeting, the two companies advised that the final analysis would occur "around the end of the year." Following this news, Mereo's American Depositary Receipt ("ADR") price fell over 42% on July 10, 2025.
If you suffered a loss on your Mereo BioPharma Group plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) concerning potential violations of the federal securities laws.
On July 9, 2025, Ultragenyx issued a press release announcing the randomized controlled portion of the Phase 3 Orbit Study for Osteogenesis Imperfecta is progressing toward final analysts for end of year but stopped short of presenting any interim results. Ultragenyx had “hoped to be able to stop the study early” if positive results were achieved at the interim analysis. Following this news, Ultragenyx’s stock price fell by $10.83 per share to open at $30.61 per share.
If you suffered a loss on your Ultragenyx Pharmaceutical Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Jasper Therapeutics, Inc. (NASDAQ: JSPR) concerning potential violations of the federal securities laws.
Jasper issued a press release on July 7, 2025, "reporting updated data from Company's BEACON Phase 1b/2a study of subcutaneous briquilimab in adult participants with CSU and providing an update on the program." The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed with drug from the lot in question. The Company is investigating the drug product lot in question and expects to have the results of that investigation in the coming weeks." Following this news, Jasper's stock price fell over 55% on July 7, 2025.
If you suffered a loss on your Jasper Therapeutics, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Funko, Inc. (NASDAQ: FNKO) concerning potential violations of the federal securities laws.
On July 7, 2025, Funko announced the departure of Cynthia Williams as its Chief Executive Officer, effective July 5, 2025. Following this news, Funko's stock price fell over 10% on the same day.
If you suffered a loss on your Funko, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into National Grid plc (NYSE: NGG) concerning potential violations of the federal securities laws.
The United Kingdom's energy system operator, National Energy System Operator ("NESO"), published a report on July 1, 2025, summarizing the findings of its investigation into the March 20, 2025 fire that caused Heathrow Airport to shut down. NESO's report stated that the fire was caused by a known fault at an electrical substation owned by National Grid, which had been aware of the problem since 2018 but failed to fix it. Media outlets subsequently reported that Heathrow Airport was considering legal action against National Grid. Following this news, National Grid's American Depositary Receipt ("ADR") price fell over 5% on July 2, 2025.
If you suffered a loss on your National Grid plc securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into The J. M. Smucker Company (NYSE: SJM) concerning potential violations of the federal securities laws.
On June 9, 2025, Smucker announced its fourth quarter and full fiscal year 2025 financial results, highlighting increased setbacks to its Sweet Baked Snacks segment. As a result, management anticipated only 3% annual net sales growth for the segment over the long-term. The Company blamed the segment’s disappointing results on inflationary pressures, diminished income and poor execution. Following this news, SJM’s stock price fell by $17.44 per share, or approximately 16% to close at $94.41 per share.
If you suffered a loss on your The J. M. Smucker Company securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Harrow, Inc. (NASDAQ: HROW) concerning potential violations of the federal securities laws.
Harrow issued a press release on May 8, 2025, announcing its financial results for the first quarter of 2025. Among other items, Harrow reported revenue of $47.8 million, missing consensus estimates of $57.0 million and -$1.9 million in adjusted EBITDA, falling short of the expected $11.9 million. Following this news, Harrow's stock price fell over 4% on the same day.
If you suffered a loss on your Harrow, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into American Outdoor Brands, Inc. (NASDAQ: AOUT) concerning potential violations of the federal securities laws.
American Outdoor issued a press release on June 26, 2025, reporting its financial results for its fourth quarter and full fiscal year 2025. Among other items, American Outdoor disclosed that retailers accelerated orders in the final weeks of the quarter, effectively pulling forward an estimated $8 million to $10 million in sales from the upcoming fiscal year. American Outdoor also announced its decision to suspend its fiscal 2026 guidance, citing uncertainties around tariffs. Following this news, American Outdoor's stock price fell over 13% on June 27, 2025.
If you suffered a loss on your American Outdoor Brands, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Quantum Corporation (NASDAQ: QMCO) concerning potential violations of the federal securities laws.
Quantum disclosed that it is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 by the original due date, and that it was “reviewing its accounting related to certain revenue contracts as well as the application of standalone selling price under applicable accounting standards.” Following this news, the price of the Company’s stock dropped on June 30, 2025.
If you suffered a loss on your Quantum Corporation securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired CTO Realty Growth, Inc. (NYSE: CTO) securities.
If you suffered a loss on your CTO Realty Growth, Inc. investment and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
THE LAWSUIT: Feb 18 2021 - Jun 24 2025
CASE DETAILS: The filed complaint alleges that CTO Realty Growth, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) CTO’s dividends were less sustainable than defendants had led investors to believe; (ii) the Company used deceptive and unsustainable practices to artificially inflate its adjusted funds from operations and overstate the true profitability of its Ashford Lane property; (iii) accordingly, CTO’s business and/or financial prospects were overstated; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Novo Nordisk A/S (NYSE: NVO) concerning potential violations of the federal securities laws.
Novo Nordisk announced on June 23, 2025, that it would end its partnership with Hims & Hers Health, Inc. ("Hims") to distribute its weight loss drug Wegovy, claiming that Hims "has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of ‘personalization' and are disseminating deceptive marketing that put patient safety at risk." Following this news, Novo Nordisk stock fell over 5% on the same day.
If you suffered a loss on your Novo Nordisk A/S securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Equinix, Inc. (NASDAQ: EQIX) concerning potential violations of the federal securities laws.
On June 25, 2025, during an Analyst Day event, Equinix shares plummeted as investors reacted to analyst and market sentiment that Equinix was not performing as well as competitors. Also during the event, Equinix announced that the company was experiencing unanticipated churn events and capacity constraints, which could impact pricing dynamics. Following this news, Equinix’s stock price fell over 9% to close at $824.31 per share on June 25, 2025.
If you suffered a loss on your Equinix, Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into New Fortress Energy Inc. (NASDAQ: NFE) concerning potential violations of the federal securities laws.
New Fortress issued a press release on May 14, 2025, reporting its financial results for the first quarter of 2025. New Fortress disclosed weak performance across its business segments. Among other items, New Fortress reported total revenue of $470.5 million, compared to $690.3 million for the same period in 2024, as well as a net loss of $197.4 million, or $0.73 per share, compared to net income of $56.7 million, or $0.26 per share for the same period in 2024. Following this news, New Fortress's stock price fell over 62% on May 15, 2025.
If you suffered a loss on your New Fortress Energy Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure






Levi & Korsinsky notifies investors that it has commenced an investigation into Aurora Cannabis Inc. (NASDAQ: ACB) concerning potential violations of the federal securities laws.
Aurora Cannabis issued a press release on June 18, 2025, reporting its financial results for the Company's fiscal fourth quarter and full year. Among other items, Aurora Cannabis advised investors to expect temporary declines in certain of its international markets in the current quarter, while warning that its adjusted EBITDA could decline as a result of lower revenue. Following this news, Aurora Cannabis's stock price fell over 20% on June 18, 2025.
If you suffered a loss on your Aurora Cannabis Inc. securities and would like to explore a potential recovery under the federal securities laws, submit to us or contact Joseph E. Levi, Esq. via email at [email protected] or call 212-363-7500 to speak to our team of experienced shareholder advocates.
Please provide your address so we can contact you about your case if eligible.






Input your stock purchases and sales












Connect with SnapTrade to let us the stocks you own. This is an optional step to keep you. informed about class action litigation.
✓ Fast: takes less than a min
✓ We do not create an attorney-client relationship
✓ Your information is confidential & secure





